Chemoinformaics analysis of (+)-p-Menthane-3,8-diol
Molecular Weight | 172.268 | nRot | 2 |
Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
Exact Molecular Weight | 172.146 | nRing | 1 |
Solubility: LogS | -1.184 | nHRing | 0 |
Solubility: LogP | 1.695 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 31.6399 |
nHD | 2 | BPOL | 20.0641 |
QED | 0.661 |
Synth | 3.772 |
Natural Product Likeliness | 2.083 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.398 |
HIA | 0.026 |
CACO-2 | -4.599 |
MDCK | 0.000120701 |
BBB | 0.532 |
PPB | 0.280369 |
VDSS | 1.003 |
FU | 0.60473 |
CYP1A2-inh | 0.103 |
CYP1A2-sub | 0.577 |
CYP2c19-inh | 0.013 |
CYP2c19-sub | 0.618 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.371 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.225 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.228 |
CL | 10.842 |
T12 | 0.804 |
hERG | 0.045 |
Ames | 0.023 |
ROA | 0.092 |
SkinSen | 0.825 |
Carcinogencity | 0.453 |
EI | 0.972 |
Respiratory | 0.754 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.905617 |